CNCE
Concert Pharmaceuticals, Inc.
CNCE
CNCE
Delisted
CNCE was delisted on the 3rd of March, 2023.
80 hedge funds and large institutions have $92.4M invested in Concert Pharmaceuticals, Inc. in 2019 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 34 increasing their positions, 22 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
100% less call options, than puts
Call options by funds: $2K | Put options by funds: $1.2M
Holders
80
Holding in Top 10
–
Calls
$2K
Puts
$1.2M
Top Buyers
| 1 | +$4.09M | |
| 2 | +$1.01M | |
| 3 | +$921K | |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$823K |
| 5 |
Russell Investments Group
London,
United Kingdom
|
+$647K |
Top Sellers
| 1 | -$19.5M | |
| 2 | -$3.69M | |
| 3 | -$1.33M | |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$1.31M |
| 5 |
Millennium Management
New York
|
-$918K |